【PHARMA 7081 交流专区】发马

icy97

PHARMANIAGA BERHAD

Date of change	01 Sep 2024
Name	ENCIK ZULKIFLI BIN JAFAR
Age	51
Gender	Male
Nationality	Malaysia
Type of change	Redesignation
Previous Position	Executive Director
New Position	Managing Director
Directorate	Executive

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Professional Qualification	Admission to Malaysian Bar in 1996,	Malaysia Bar
2	Professional Qualification	Advocate and Solicitor	High Court of Malaya
3	Professional Qualification	Certified Patent Agent	-
4	Degree	Bachelor of Laws	Universiti Islam Antarabangsa Malaysia

Working experience and occupation

March 2024 to Present - Executive Director, Pharmaniaga BerhadJuly 2023 to Present - Chairman, Advisory Panel (Faculty of Shariah and Law), University Sains Islam Malaysia (USIM)June 2023 to Present - Chairman, USIM Tijarah Holdings Sdn BhdJune 2023 to Present - Director, PT Errita Pharma, IndonesiaMay 2023 to Present - Director, PT Millennium Pharmacon International, IndonesiaFebruary 2023 to Present - Chairman of Investment Committee (USIM)February 2023 to Present - Committee Member of Disciplinary Committee (USIM)February 2023 to February 2024 - Deputy Chief Executive Officer, Pharmaniaga BerhadJanuary 2023 until Present - Director, University Sains Islam Malaysia (USIM)March 2022 to February 2023 - Group Executive Director, Pharmaniaga Berhad30 September 2022 to Present - Board of Director, Idaman Pharma Manufacturing Sdn Bhd2020 to March 2022 - Committee Member of Nomination and Remuneration Committee, Audit Committee & Board Risk Management Committee2020 to March 2022 - Chairman of Board Tender Committee Pharmaniaga Berhad2020 to February 2023 - Director Pharmaniaga Berhad (PLC)2014 to Present - Chairman and Director of Era Universe Development Sdn Bhd.2016 to 2019 - Legal Advisor of Johor State GLC2015 to 2021 - Director for Foundation of Research and Transformation (Prime Ministers Office)2015 to Present - Director of Chartridge Conference Centre, United Kingdom2015 to 2019 - Director of Aladdin Group Sdn Bhd2012 to 2015 - Director of Songa Offshore Malaysia Sdn Bhd2008 to 2010 - Director of Cooperative Commission of Malaysia2007 to Present - Major Shareholder and Director of MMA Resources Sdn Bhd2002 to 2020 - Partner of Messrs Rashid Zulkifli1997 to 2002 - Senior Legal Assistant for Messrs Raslan Loong1997 - Legal Counsel for Panglima Aces Sdn Bhd

icy97

PHARMANIAGA BERHAD

Date of change	01 Oct 2024
Name	DATO' SERI ABDUL RAZAK BIN JAAFAR
Age	60
Gender	Male
Nationality	Malaysia
Designation	Chairman
Directorate	Independent and Non Executive
Type of change	Appointment

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Masters	Master in Science, Human Resource Development	Universiti Putra Malaysia
2	Others	Postgraduate Diploma in Public Management	National Institute of Public Administration (INTAN)
3	Degree	Bachelor in Communication with Honors	Universiti Kebangsaan Malaysia

Working experience and occupation

2021 to 2023 : Secretary General, Ministry of Higher Education (KPT) 2019 : State Secretary, Penang State Government 2015 : Deputy Secretary General (Policy & Development), Ministry of Works (KKR) 2013 : Division Secretary, Finance Division, Deputy Division Secretary, Procurement Division, Ministry of Defense (MINDEF) 2012 : Section Director (Security, Housing, Local Authority & Land Development), Public-Private Partnership Unit, Prime Minister's Office (UKAS, PMO) Administrative and Diplomatic Officer (PTD), Post-Service Division, Public Service Department (JPA) 2009 : President of Local Authority (Yang DiPertua), Kuala Langat Municipal Council 2006 : Deputy President of Local Authority (Timbalan Yang DiPertua), Sepang Municipal Council 2003 : Director, Department of Corporate Planning, Ampang Jaya Municipal Council 2002 : Director, Department of Community Development, Petaling Jaya Municipal Council 2000 : Assistant Secretary (Scholarship & Training), Selangor State Government 1998 : Assistant Secretary (Services Division), Selangor State Government 1996 : Head of Department (Internal Audit & Public Complaint), Selangor State Government 1992 : Assistant Director (Federal Special Task Force, Sabah Branch), National Security Council (MKN), Prime Minister's Office 1991 : Administrative and Diplomatic Cadet (PTD), Public Service Department (JPA) 1988 : Public Relations Officer, Seremban City Council

Date of change	01 Oct 2024
Name	ENCIK IZADDEEN BIN DAUD
Age	55
Gender	Male
Nationality	Malaysia
Type of change	Redesignation
Previous Position	Chairman
New Position	Non-Independent Director
Directorate	Non Independent and Non Executive

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Professional Qualification	Certified Financial Planner	Financial Planning Association of Malaysia
2	Professional Qualification	Public Accountant	Institute of Public Accountant, Australia	Fellow Member
3	Degree	B.Sc (Honours) Accounting and Law	De Monfort University, Leicester, United Kingdom

Working experience and occupation

30 November 2022 to Present : Group Chief Executive Officer, Boustead Holdings Berhad 1 March 2021 to 29 November 2022 : Deputy Group Managing Director, Boustead Holdings Berhad 2013 to January 2021 : Executive Chairman, E&E Gas Sdn Bhd  November 2020 to March 2022 : Acting Chief Executive Officer, Boustead Properties Berhad  July 2020 to February 2021 : Executive Director, Group Business Development, Boustead Holdings Berhad  (BHB)  2008 to 2009 : Managing Director, MARA Incorporated  2007 to 2008 : Chief Executive Officer, ASM Investment Services Berhad  1999 to 2007 :  Assistant Vice President, Permodalan Nasional Berhad  1992 to 1998 : Senior Manager, Perwira Affin Merchant Bank Berhad  1992 : Senior Officer, Oriental Bank Berhad  1991 : Auditor, Ernst & Young

icy97

PHARMANIAGA BERHAD

Date of change	01 Oct 2024
Name	ENCIK AHMAD SHAHREDZUAN BIN MOHD SHARIFF
Age	41
Gender	Male
Nationality	Malaysia
Designation	Director
Directorate	Non Independent and Non Executive
Type of change	Resignation
Reason	Appointed as the Chief Operating Officer of the Company
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of shareholders	No

Qualifications

No	Qualifications	Major/Field of Study	Institute/University	Additional Information
1	Degree	Bachelor of Economics	University of Warwick, United Kingdom
2	Diploma	Graduate Diploma of Applied Finance	Kaplan Higher Education, Australia

Working experience and occupation	February 2023 to September 2024 : Non-Independent Non-Executive Director, Pharmaniaga Berhad March 2021 to September 2024 : Group Chief Reinvention & Strategy Officer, Boustead Holdings Berhad (BHB) May 2020 to February 2021 : Chief Transformation Officer, (BHB)December 2019 to April 2020 : Senior General Manager, (BHB) June 2015 to November 2019 : Implementation Consultant, McKinsey & Company, Kuala Lumpur, Malaysia August 2006 to June 2015 : Various positions in Permodalan Nasional Berhad. Last position was Senior Manager at the Office of President and Group Chief Executive
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Nil

Date of change	01 Oct 2024
Name	ENCIK AHMAD SHAHREDZUAN BIN MOHD SHARIFF
Age	41
Gender	Male
Nationality	Malaysia
Type of change	Appointment
Designation	Chief Operating Officer

Qualifications

No Qualifications Major/Field of Study Institute/University Additional Information 1 Degree Bachelor of Economics University of Warwick, United Kingdom 2 Diploma Graduate Diploma of Applied Finance Kaplan Higher Education, Australia
Working experience and occupation	February 2023 to September 2024 : Non-Independent Non-Executive Director, Pharmaniaga BerhadMarch 2021 to September 2024 : Group Chief Reinvention & Strategy Officer, Boustead Holdings Berhad (BHB) May 2020 to February 2021 : Chief Transformation Officer, (BHB) December 2019 to April 2020 : Senior General Manager, (BHB) June 2015 to November 2019 : Implementation Consultant, McKinsey & Company, Kuala Lumpur, Malaysia  August 2006 to June 2015 : Various positions in Permodalan Nasional Berhad. Last position was Senior  Manager at the Office of President and Group Chief Executive

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2024	31 Dec 2023	31 Dec 2024	31 Dec 2023
		MYR'000	MYR'000	MYR'000	MYR'000

1	Revenue	926,442	789,807	3,759,479	3,404,481
2	Profit/(loss) before tax	13,317	-37,439	194,180	-78,163
3	Profit/(loss) for the period	2,450	-34,787	133,794	-78,744
4	Profit/(loss) attributable to ordinary equity holders of the parent	2,347	-35,429	131,822	-80,160
5	Basic earnings/(loss) per share (Subunit)	0.16	-2.59	9.15	-5.86
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent	-0.1188		-0.2075

icy97

Type	Announcement
Subject	AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN MATERIAL UNCERTAINTY RELATED TO GOING CONCERN
Description	STATEMENT OF MATERIAL UNCERTAINTY RELATED TO GOING CONCERN IN RESPECT OF THE  FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2024
Please refer to the file attached for further details. This announcement is made on 29 April 2025.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3548890

Attachments Statement of Material Uncertainty Related to Going Concern - 29 April 2025.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2025

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2025	31 Mar 2024	31 Mar 2025	31 Mar 2024
		MYR'000	MYR'000	MYR'000	MYR'000

1	Revenue	1,055,349	964,959	1,055,349	964,959
2	Profit/(loss) before tax	45,503	39,044	45,503	39,044
3	Profit/(loss) for the period	30,248	26,179	30,248	26,179
4	Profit/(loss) attributable to ordinary equity holders of the parent	29,579	25,646	29,579	25,646
5	Basic earnings/(loss) per share (Subunit)	2.05	1.78	2.05	1.78
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent	-0.1000		-0.1188

icy97

PHARMANIAGA BERHAD

Entitlement subject	Rights Issue
Type	Renounceable
Entitlement description	RENOUNCEABLE RIGHTS ISSUE OF UP TO 3,521,543,102 NEW ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA SHARES" OR "SHARES") ("RIGHTS SHARES") AT AN ISSUE PRICE OF RM0.10 PER RIGHTS SHARE ON THE BASIS OF 12 RIGHTS SHARES FOR EVERY 5 EXISTING PHARMANIAGA SHARES HELD AS AT 5.00 P.M. ON 2 JULY 2025 ("RIGHTS ISSUE")
Ex-Date	01 Jul 2025
Entitlement date	02 Jul 2025
Entitlement time	5:00 PM
Share transfer book & register of members will be	to  closed from (both dates inclusive) for the purpose of determining the entitlement
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers	02 Jul 2025
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Rights Issue/Offer Price	Malaysian Ringgit (MYR) 0.1000
Par Value (if applicable)
Entitlement indicator	Ratio
Entitlement Details
Company Name	PHARMANIAGA BERHAD
Entitlement	Ordinary Rights
Ratio (New:Existing)	12.0000  : 5.0000
Rights Crediting Date	02 Jul 2025

Despatch Date	04 Jul 2025
Date for commencement of trading of rights	03 Jul 2025
Date for cessation of trading of rights	10 Jul 2025
Date for announcement of final subscription result and basis of allotment of excess Rights Securities	24 Jul 2025
Last date and time for :
Sale of provisional allotment of rights	09 Jul 2025 05:00 PM
Transfer of provisional allotment of rights	11 Jul 2025 04:30 PM
Acceptance and Payment	17 Jul 2025 05:00 PM
Excess share application and payment	17 Jul 2025 05:00 PM
Available/Listing Date	31 Jul 2025

icy97

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 REGULARISATION PLAN
Description	PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY")REGULARISATION PLAN
Unless otherwise defined, capitalised terms used in this announcement shall carry the same meanings as those given to them in the announcements dated 29 November 2023, 19 February 2024, 23 February 2024, 6 November 2024, 29 November 2024, 4 February 2025, 17 February 2025, 18 February 2025, 19 February 2025, 26 February 2025, 27 February 2025, 20 March 2025, 15 May 2025, 22 May 2025, 17 June 2025, 1 July 2025 and 2 July 2025 in relation to the Regularisation Plan (“Announcements”). Reference is made to the Announcements. On behalf of the Board, MBSB Investment Bank Berhad (formerly known as MIDF Amanah Investment Bank Berhad) (“MBSB IB”) is pleased to announce that as at the closing of acceptance, excess application and payment for the Rights Issue at 5.00 p.m. on 17 July 2025 (“Closing Date”), Pharmaniaga had received valid acceptances and excess applications for a total of 4,363,033,957 Rights Shares, representing a subscription rate of 126.14% of the total number of 3,458,950,862 Rights Shares available for subscription, resulting in an over-subscription rate of 26.14%. Details of the valid acceptances and excess applications received as at the Closing Date are as follows:- Number of Rights Shares As a percentage of the total Rights Shares available for subscription (%) Total valid acceptances 3,187,081,147 92.14 Total valid excess applications 1,175,952,810 34.00 Total valid acceptances and excess applications 4,363,033,957 126.14 Total number of Rights Shares available for subscription 3,458,950,862 100.00 Over subscription 904,083,095 26.14 The excess Rights Shares have been allocated in accordance with the basis as stated in the Abridged Prospectus dated 2 July 2025.The Rights Shares are expected to be listed and quoted on the Main Market of Bursa Securities on 31 July 2025. This announcement is dated 24 July 2025.

icy97

PHARMANIAGA BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Rights Issue
Details of corporate proposal	RENOUNCEABLE RIGHTS ISSUE OF 3,458,950,862 NEW ORDINARY SHARES IN PHARMANIAGA BERHAD ("PHARMANIAGA SHARES" OR "SHARES") ("RIGHTS SHARES") AT AN ISSUE PRICE OF RM0.10 PER RIGHTS SHARE ON THE BASIS OF 12 RIGHTS SHARES FOR EVERY 5 EXISTING PHARMANIAGA SHARES HELD AS AT 5.00 P.M. ON 2 JULY 2025 ("RIGHTS ISSUE")
No. of shares issued under this corporate proposal	3,458,950,862
Issue price per share	Malaysian Ringgit (MYR)   0.1000
Par Value (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	4,900,180,388
Issued Share Capital	Malaysian Ringgit (MYR) 545,941,374.300
Listing Date	31 Jul 2025

icy97

PHARMANIAGA BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN PHARMANIAGA BERHAD ("PLACEMENT SHARES") TO THIRD PARTY INVESTOR(S) AT AN ISSUE PRICE OF RM0.135 PER PLACEMENT SHARE
No. of shares issued under this corporate proposal	1,656,845,000
Issue price per share	Malaysian Ringgit (MYR)   0.1350
Par Value (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	6,557,025,388
Issued Share Capital	Malaysian Ringgit (MYR) 769,615,449.300
Listing Date	31 Jul 2025

icy97

PHARMANIAGA BERHAD

Particulars of substantial Securities Holder

Name	BOUSTEAD HOLDINGS BERHAD
Address	Level 23, The Bousteador, No. 10, Jln PJU 7/6, Mutiara Damansara Petaling Jaya 47800 Selangor Malaysia.
Company No.	196001000193 (3871-H)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	29 Jul 2025	1,629,964,980	Acquired	Direct Interest
	Name of registered holder	BOUSTEAD HOLDINGS BERHAD
	Address of registered holder	Level 23, The Bousteador, No. 10, Jln PJU 7/6,Mutiara Damansara 47800, Petaling Jaya Selangor
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquisition of Shares via Rights Issue
Nature of interest	Direct Interest
Direct (units)	1,629,964,980
Direct (%)	35.215
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	2,309,117,055
Date of notice	31 Jul 2025
Date notice received by Listed Issuer	31 Jul 2025

Name	LEMBAGA TABUNG ANGKATAN TENTERA
Address	TINGKAT 10-12, BANGUNAN LTAT JALAN BUKIT BINTANG KUALA LUMPUR 55100 Wilayah Persekutuan Malaysia.
Company No.	ACT101973
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	29 Jul 2025	456,605,189	Acquired	Direct Interest
	Name of registered holder	LEMBAGA TABUNG ANGKATAN TENTERA
	Address of registered holder	TINGKAT 10-12, BANGUNAN LTAT JALAN BUKIT BINTANG 55100 KUALA LUMPUR
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Acquisition of Shares via Rights Issue
Nature of interest	Direct Interest
Direct (units)	456,605,189
Direct (%)	8.69
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	569,521,809
Date of notice	31 Jul 2025
Date notice received by Listed Issuer	31 Jul 2025

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

PHARMANIAGA BERHAD

Particulars of Substantial Securities Holder

Name	JAKEL MEDICAL SDN BHD
Address	NO. 31-1, JALAN TASIK SELATAN 3 METRO CENTRE Kuala Lumpur 57000 Wilayah Persekutuan Malaysia.
Company No.	202501019786 (1621199-T)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name of registered holder	MALACCA EQUITY NOMINEES (TEMPATAN) SDN BHD PLEDGED SECURTIES ACCOUNT FOR JAKEL MEDICAL SDN BHD
Address of registered holder	NO.1,3&5 JALAN PPMPLAZA PANDAN MALIM BUSINESS PARK,BALAI PANJANG, 75250 MELAKA

Date interest acquired & no of securities acquired
Date interest acquired	29 Jul 2025
No of securities	655,745,000
Circumstances by reason of which Securities Holder has interest	Acquisition of Shares via Private Placement
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	655,745,000
Direct (%)	10
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	31 Jul 2025
Date notice received by Listed Issuer	31 Jul 2025